Testing effectiveness (Phase 2)Study completedNCT04173793
What this trial is testing
PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Who this might be right for
Heterozygous Familial Hypercholesterolemia
Akeso 109